11

ACB $5.930 (+3.49%)

11

ACB:APH $7.930 (+3.39%)

11

ACNNF $0.460 (+0%)

11

ADENF $0.000 (+0%)

AERO $2.280 (-2.15%)

11

AGTK $0.003 (+6.25%)

11

ALEAF $1.108 (+1.62%)

ALEF:APH $1.450 (-4.61%)

11

AMMJ $0.400 (+12.36%)

11

APHA $6.140 (+9.45%)

11

APHA:APH $8.200 (+8.9%)

ARNA $40.970 (-0.1%)

11

ATT:CNX $0.090 (+5.88%)

11

ATTBF $0.067 (+1.21%)

11

AUSA:CNX $0.790 (+0%)

11

AVXL $2.120 (+0.95%)

11

AXIM $0.935 (+2.75%)

11

BAMM:CNX $0.620 (+8.77%)

11

BE:CNX $0.110 (+4.76%)

BIO:CNX $0.490 (-5.77%)

11

BITCF $0.092 (+2.22%)

BLEVF $0.079 (-4.01%)

BLIS:CNX $0.300 (-4.76%)

11

BLO:CNX $1.610 (+0%)

11

BLOK:APH $0.105 (+0%)

11

BLOZF $1.215 (+0.41%)

11

BLPG $0.002 (+0%)

BUDZ $1.891 (-3.03%)

11

BXNG $0.450 (+24.65%)

11

CADMF $0.819 (+4.89%)

11

CALI:CNX $0.120 (+0%)

CANL $0.140 (-0.67%)

CANN $2.170 (-6.47%)

CARA $15.700 (-0.82%)

11

CBDS $4.050 (+3.85%)

11

CBIS $0.035 (+4.63%)

11

CBWTF $0.580 (+2.66%)

11

CGC $33.160 (+6.9%)

11

CGRW $0.800 (+10.27%)

11

CHOO:CNX $0.600 (+17.65%)

11

CHOOF $0.445 (+18.88%)

11

CNAB $0.450 (+0.08%)

11

CNBX $0.410 (+10.81%)

CNGGF $1.460 (-2.67%)

11

CNNRF $0.000 (+0%)

11

CNTTF $5.998 (+7.59%)

11

CNZCF $0.000 (+0%)

CODI $14.150 (-2.21%)

CPMD $1.886 (-12.28%)

11

CRBP $6.900 (+2.07%)

CRON $12.820 (-0.47%)

11

CRON:APH $17.120 (+0.18%)

11

CROP:CNX $0.375 (+1.35%)

11

CRPGF $0.000 (+0%)

11

CRWG $0.003 (+3.13%)

11

CRXPF $0.286 (+3.88%)

11

CRZ:CNX $0.000 (+0%)

11

CSI:CNX $1.050 (+11.7%)

CURR $1.280 (-5.88%)

11

CVSI $5.210 (+5.36%)

11

CWEB:CNX $16.000 (+6.67%)

11

CXBS $0.100 (+0%)

11

CYX:APH $0.030 (+0%)

DIGP $0.135 (-6.9%)

11

DJACF $2.100 (+0%)

EAPH $0.010 (-4.54%)

EAT:CNX $0.200 (-4.76%)

11

EEVVF $0.241 (+14.09%)

11

EMC:APH $1.040 (+2.97%)

11

EMH:APH $2.780 (+2.21%)

11

EMHTF $2.080 (+1.96%)

11

EMMBF $0.786 (+2.55%)

11

EPW:CNX $0.100 (+11.11%)

11

EPWCF $0.072 (+2.86%)

11

ERBB $0.000 (+0%)

11

EVE:APH $0.325 (+18.18%)

EVIO $0.409 (-2.45%)

FFRMF $0.191 (-1.04%)

11

FFT:CNX $0.270 (+1.89%)

11

FIRE:APH $1.450 (+1.4%)

11

FNNZF $0.090 (+0%)

FSDDF $0.236 (-1.21%)

GBLX $0.195 (-0.71%)

GENE:APH $1.030 (-4.63%)

GGTTF $0.416 (-3.02%)

GLDFF $0.098 (-1.52%)

11

GLH:CNX $0.135 (+0%)

GLNNF $0.130 (-7.14%)

GNBT $0.710 (-11.25%)

GRNH $0.019 (-0.26%)

GRSO $0.005 (-8.57%)

11

GRWC $0.073 (+0.34%)

11

GRWG $2.980 (+1.88%)

11

GTBIF $9.898 (+1.74%)

GTEC:APH $0.560 (-1.75%)

11

GTII:CNX $13.250 (+1.38%)

11

GTSO $0.032 (+29.03%)

11

GWPH $122.990 (+0.17%)

HC:CNX $0.295 (-9.23%)

11

HEMP $0.034 (+2.7%)

11

HEMP:APH $1.400 (+23.89%)

11

HERB $0.030 (+15.44%)

11

HEXO:APH $5.320 (+5.35%)

HHPHF $0.231 (-5.56%)

11

HIKU:CNX $0.000 (+0%)

11

HIP:APH $0.415 (+3.75%)

11

HLSPY $0.740 (+4.23%)

11

HMLSF $12.666 (+1.49%)

11

HMPPF $1.046 (+24.52%)

11

HRVOF $0.320 (+2.12%)

11

HSTRF $0.244 (+1.25%)

HUGE:CNX $0.305 (-3.18%)

11

HVT:APH $0.430 (+4.88%)

11

HYYDF $3.995 (+6.35%)

11

IAN:CNX $6.250 (+2.63%)

11

ICAN:CNX $0.550 (+18.28%)

11

ICC:APH $0.000 (+0%)

11

ICCLF $1.233 (+0%)

11

ICNAF $0.396 (+13.39%)

11

IGC $0.000 (+0%)

IGX:APH $0.740 (-6.33%)

IGXT $0.570 (-1.89%)

IIPR $50.470 (-0.04%)

11

IMH:APH $0.000 (+0%)

11

IMLFF $0.333 (+4.3%)

11

IN:APH $0.450 (+7.14%)

INQD $0.057 (-2.24%)

INSY $5.060 (-1.56%)

11

ISOL:CNX $1.770 (+7.93%)

11

ISOLF $1.340 (+9.81%)

11

ITHUF $4.660 (+2.42%)

IVITF $0.781 (-4.73%)

JWCA:APH $0.600 (-4.76%)

JWCAF $0.446 (-4.42%)

KALTF $0.055 (-10.43%)

11

KAYS $0.105 (+0%)

11

KHRN:APH $1.420 (+6.77%)

11

KHRNF $1.060 (+4.71%)

KSHB $5.870 (-0.85%)

11

LABS:APH $1.330 (+0%)

11

LDS:CNX $0.390 (+11.43%)

11

LDSYF $0.288 (+4.2%)

11

LHS:CNX $1.060 (+11.58%)

11

LHSIF $0.795 (+12.77%)

11

LIFT:APH $0.310 (+0%)

LIHT:CNX $0.180 (-2.7%)

LIHTF $0.140 (-4.7%)

11

LVWL:APH $0.000 (+0%)

11

LVWL:CNX $0.740 (+0%)

11

LXLLF $0.547 (+0%)

LXRP $1.120 (-9.68%)

LXX:CNX $1.480 (-9.2%)

11

MARI:CNX $0.000 (+0%)

MCIG $0.183 (-5.78%)

MDCL $1.430 (-1.38%)

11

MGWFF $0.110 (+15.79%)

MICWF $0.226 (-4.77%)

11

MJ:CNX $0.415 (+1.22%)

MJNA $0.070 (-1.41%)

MJTK $0.000 (-25%)

11

MLCPF $1.097 (+0.52%)

MNTR $0.470 (-7.84%)

11

MPX:CNX $0.950 (+1.06%)

11

MPXEF $0.710 (+2.18%)

MRRCF $0.852 (-1.21%)

MSRT $0.095 (-2.11%)

11

MWM:CNX $0.310 (+1.64%)

MYDX $0.002 (-4.55%)

11

MYM:CNX $0.590 (+0%)

11

MYMMF $0.445 (+3.49%)

11

N:APH $1.340 (+2.29%)

NCNNF $0.520 (-1.48%)

NDEV $0.180 (-9.77%)

11

NDVA:APH $0.530 (+3.92%)

NDVAF $0.390 (-2.5%)

NGW:CNX $0.360 (-10%)

11

NINE:APH $1.260 (+0.8%)

NMUS $0.321 (-5.37%)

11

NPK:APH $0.790 (+0%)

11

NRTH:APH $0.710 (+0%)

NRXCF $0.058 (-6.58%)

11

NSP:APH $0.135 (+0%)

NSPDF $0.096 (-2.24%)

NTEC $7.500 (-2.34%)

NTRR $0.023 (-18.89%)

11

NVTQF $0.019 (+0%)

NWKRF $0.304 (-1.27%)

11

NXTTF $1.009 (+3.81%)

11

OGI:APH $4.970 (+4.85%)

11

OGRMF $3.720 (+4.79%)

11

OH:CNX $6.450 (+0%)

ORHOF $4.750 (-1.44%)

11

ORTFD $0.000 (+0%)

11

OWCP $0.148 (+0.27%)

11

PHGI:APH $0.000 (+0%)

11

PHGRF $0.780 (+9.23%)

11

PHVAF $0.505 (+4.69%)

11

PILL:CNX $1.070 (+0.94%)

11

PKPH $0.120 (+0%)

11

PMCB $0.046 (+0.11%)

11

PNPL $0.950 (+0%)

PNTV $0.047 (-3.47%)

11

POTN $0.128 (+13.69%)

PRCNF $0.121 (-0.25%)

11

PUF:CNX $0.000 (+0%)

11

PUFXF $0.122 (+16.1%)

11

PURE:APH $0.155 (+0%)

QCA:CNX $0.250 (-3.85%)

11

RDDTF $0.587 (+1.12%)

11

REFG $0.019 (+3.82%)

11

RHT:APH $0.260 (+0%)

11

RLLVF $0.071 (+18.17%)

11

RLTY:CNX $0.000 (+0%)

11

RLV:APH $0.090 (+12.5%)

11

RLVVF $0.000 (+0%)

11

RMHB $0.011 (+2.94%)

11

RQB:APH $0.000 (+0%)

RQB:CNX $0.490 (-5.77%)

11

RQHTF $0.192 (+1.05%)

11

RTI:APH $0.790 (+1.28%)

11

RVV:APH $0.100 (+0%)

RVVQF $0.368 (-9.52%)

RVVTF $0.068 (-12.56%)

11

SAGD $0.005 (+0%)

11

SING $0.016 (+0.62%)

11

SLTK $0.000 (+0%)

SMG $66.140 (-3.23%)

11

SNN:CNX $3.180 (+3.25%)

11

SNNVF $2.380 (+0.25%)

11

SPLIF $0.155 (+0.19%)

11

SPRWF $1.090 (+1.75%)

SRNA $0.079 (-7.33%)

SSWH $0.360 (-10.01%)

11

SUWN $0.075 (+0%)

11

TBP:APH $0.940 (+3.3%)

TBPMF $0.696 (-0.26%)

11

TDRYF $0.309 (+0%)

TER:CNX $6.350 (-2.46%)

11

TGEN $3.800 (+0%)

TGIF:CNX $0.395 (-3.66%)

TGIFF $0.297 (-4.36%)

11

TGOD:APH $3.130 (+2.96%)

11

TGODF $2.310 (+0.87%)

THC:CNX $0.405 (-2.41%)

11

THCBF $0.300 (+0%)

11

THCX:APH $0.000 (+0%)

TLRY $94.070 (-3.16%)

11

TOKI:CNX $0.250 (+4.17%)

11

TRKWF $0.174 (+1.16%)

TRLFF $0.309 (-5.44%)

TRPX $4.960 (-6.42%)

TRSSF $4.790 (-1.24%)

11

TRST:APH $8.010 (+7.81%)

11

TRTC $0.999 (+4.05%)

TURV $0.105 (-5%)

UBQU $0.001 (-15.39%)

VAPE $0.002 (-10.53%)

VBIO $1.050 (-3.67%)

11

VFF:APH $5.590 (+4.29%)

11

VFFIF $4.198 (+5.75%)

11

VIDA:CNX $0.700 (+7.69%)

11

VIN:CNX $0.520 (+0%)

11

VIVO:APH $0.890 (+2.3%)

VMNT $0.040 (-51.13%)

11

VPRB $0.062 (+3.69%)

VRNDF $0.944 (-0.01%)

VRT:CNX $0.115 (-4.17%)

VRTHF $0.088 (-4.58%)

11

VVCIF $0.650 (+0.48%)

WAYL:CNX $1.150 (-3.36%)

11

WDDMF $0.961 (+2.49%)

11

WEED:APH $44.300 (+6.24%)

11

WMD:APH $1.260 (+0%)

11

XLY:APH $0.780 (+1.3%)

11

XXII $2.840 (+2.53%)

11

ZDPY $0.360 (+2.86%)

11

ZYNE $4.660 (+0.87%)

Articles > MedMen Acquires First Dispensary in San Francisco Bay Area

MedMen Acquires First Dispensary in San Francisco Bay Area
October 10, 2018

MedMen Enterprises Inc. (CSE: MMEN) (OTCQB: MMNFF) today announced that it has signed a definitive agreement (the “Agreement”) to acquire a licensed dispensary from Berkeley Patients Group (“BPG”) in Emeryville, California. As a result of the transaction, MedMen will have one of only two adult-use licenses issued in the City of Emeryville, just outside San Francisco.

The dispensary is located in a young professional hub of the East Bay, between Oakland and Berkeley. The City of Emeryville is home to the national headquarters of numerous corporations including Pixar Animation Studios, Peet’s Coffee & Tea, Jamba Juice and Cliff Bar. The store is expected to open in 2019 and will be located at 3996 San Pablo Avenue, across the street from the Bay Street Emeryville Shopping Center, which features more than 50 businesses with over 450,000 square feet of retail space.

“California is the world’s largest legal cannabis market,” said Adam Bierman, MedMen chief executive and co-founder. “We are very proud of the footprint we’ve already established in our home state and look forward to expanding our reach to all corners of the Golden State, starting with our first store in Northern California.”

MedMen, based in Los Angeles, currently operates eight dispensaries in Southern California. The Emeryville dispensary is located in the commercial heart of the East Bay. It is positioned at the intersection of three major interstate highways that see over 600,000 daily commuters from Oakland, Berkeley, San Francisco and other cities.

As consideration for the acquisition, the Company will pay a combination of cash at closing and shares of MedMen Enterprises, Inc. in an undisclosed amount*. The transaction is expected to close within 90 days of signing and is subject to customary closing conditions.

*Company does not disclose deal values for transactions it deems immaterial from a purchase price standpoint.

ABOUT MEDMEN:

MedMen is a leading cannabis company headquartered in the U.S. with assets and operations across the country. Based in Los Angeles, MedMen brings expertise and capital to the cannabis industry and is one of the nation’s largest financial supporters of progressive marijuana laws. Visit http://www.medmen.com

Cautionary Note Regarding Forward-Looking Information and Statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only MedMen’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of MedMen’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. The forward-looking information and forward-looking statements contained herein may include, but are not limited to, information concerning the proposed acquisition, expectations regarding whether the proposed acquisition will be consummated, including whether conditions to the consummation of the proposed acquisition will be satisfied and whether the proposed acquisition will be completed on the current terms, the timing for completing the proposed acquisition, expectations for the effects of the proposed acquisition or the ability of the Company to successfully achieve business objectives, expectations regarding the California cannabis market and expectations for other economic, business, and/or competitive factors.

By identifying such information and statements in this manner, MedMen is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of MedMen to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, MedMen has made certain assumptions. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information and statements are the following: the ability to consummate the proposed acquisition; the ability to obtain requisite regulatory approvals and third party consents and the satisfaction of other conditions to the consummation of the proposed acquisition on the proposed terms and schedule; the potential impact of the announcement or consummation of the proposed acquisition on relationships, including with regulatory bodies, employees, suppliers, customers and competitors; changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; compliance with extensive government regulation; and the diversion of management time on the proposed acquisition. Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.

Although MedMen believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and MedMen does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to MedMen or persons acting on its behalf is expressly qualified in its entirety by this notice.

SOURCE: MedMen Enterprises

View source version on businesswire.com: https://www.businesswire.com/news/home/20181010005319/en/

MedMen Enterprises Inc.
MEDIA CONTACT:
Briana Chester
Senior Publicist
(424) 888-4260
briana.chester@medmen.com
or
INVESTOR RELATIONS CONTACT:
Stéphanie Van Hassel
Head of Investor Relations
(323) 705-3025
investors@medmen.com

Copyright Business Wire 2018
Source: Business Wire (October 10, 2018 - 6:00 AM EDT)

News by QuoteMedia
www.quotemedia.com

Share this Article